ACBI1 demonstrated anti-proliferative effects and induced cell death caused by SMARCA2 depletion in SMARCA4 mutant cancer cells, along with impacts in AML cells reliant on SMARCA4 ATPase activity. The gene discussed is SMARCA4; the disease is cancer.